Northstar Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$331K Sell
751
-35
-4% -$14.5K 0.15% 110
2020
Q2
$284K Sell
786
-75
-9% -$25.1K 0.12% 144
2020
Q1
$244K Sell
861
-225
-21% -$70.9K 0.12% 139
2019
Q4
$352K Sell
1,086
-85
-7% -$25.8K 0.14% 135
2019
Q3
$341K Sell
1,171
-315
-21% -$90.2K 0.15% 137
2019
Q2
$436K Sell
1,486
-115
-7% -$31.7K 0.19% 119
2019
Q1
$438K Hold
1,601
0.2% 115
2018
Q4
$358K Hold
1,601
0.19% 122
2018
Q3
$390K Buy
1,601
+16
+1% +$3.68K 0.19% 118
2018
Q2
$328K Hold
1,585
0.16% 141
2018
Q1
$327K Buy
+1,585
New +$333K 0.17% 142

Other funds holding TMO

Northstar Wealth Partners's TMO Position: Q3 2020 in Review

Northstar Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 4.5% in Q3 2020, selling an estimated $14.5K and leaving 751 shares worth $331K. The position accounts for 0.15% of the portfolio, ranked #110.

Northstar Wealth Partners first reported a position in TMO in Q1 2018 and has held it in 11 quarters since. The position peaked at $438K in Q1 2019. 1,848 funds tracked by Wall St. Rank hold TMO as of Q3 2020.

  • Northstar Wealth Partners held 751 shares of Thermo Fisher Scientific worth $331K as of Q3 2020.
  • Northstar Wealth Partners sold 35 Thermo Fisher Scientific shares in Q3 2020, an estimated $14.5K.
  • Thermo Fisher Scientific made up 0.15% of Northstar Wealth Partners's portfolio in Q3 2020, its #110 holding.
  • Northstar Wealth Partners first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 11 quarters since.
  • Northstar Wealth Partners's Thermo Fisher Scientific position peaked at $438K in Q1 2019.
  • 1,848 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.